HOME >> MEDICINE >> NEWS
Electroacupuncture trial is NCCAM's first intramural study

The National Center for Complementary and Alternative Medicine (NCCAM) has launched a clinical trial of electroacupuncture to determine if it reduces the delayed nausea experienced by cancer patients following chemotherapy. This study marks the first clinical trial for NCCAM's Division of Intramural Research, which was established in April 2001, at the National Institutes of Health (NIH) in Bethesda, MD.

Electroacupuncture, which has been in use for decades, is a variation of traditional acupuncture. In this process, acupuncture needles are placed at selected points and then pulsed with an electric current to stimulate the acupuncture points. Electroacupuncture has been studied for a variety of health conditions including treatment of pain and relief of acute nausea following chemotherapy. Acute nausea occurs within the first 24 hours after chemotherapy, whereas delayed nausea occurs 24 hours to 5 days after chemotherapy.

"The scientific evidence supporting use of electroacupuncture for relief of acute nausea following chemotherapy is very encouraging," said Marc Blackman, M.D., Director of NCCAM's Division of Intramural Research. "Now we need to look at its potential utility for treating delayed post-chemotherapy nausea, a problem for many cancer patients that needs to be investigated."

The randomized trial will enroll 52 patients, aged 16 to 35 years, who have been diagnosed with pediatric sarcomas and are starting their first course of chemotherapy. Standard treatment for pediatric sarcomas involves chemotherapy regimens that are likely to cause both acute and delayed nausea. Patients will be divided into two groups--a treatment group that receives electroacupuncture and a control group that receives sham needling. Sham needling involves placement of acupuncture needles near acupuncture points, but in sites that are considered to have no treatment effect on nausea or emesis (vomiting). The patients and investigators, except for the acupun
'"/>

Contact: NCCAM Press Office
301-451-8876
NIH/National Center for Complementary and Alternative Medicine
12-Jun-2002


Page: 1 2 3

Related medicine news :

1. Lack of clinical trial participation may contribute to lower survival rates
2. Protecting children from industrial chemicals in the environment
3. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
4. US attempting to flout ethical practice for patient trials abroad
5. NIAID initiates trial of experimental avian flu vaccine
6. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
7. WISE study starts in Toulouse: 60 days of bed-rest for terrestrial female astronauts
8. Sharing clinical trial results with participants may be beneficial
9. Emergency clopidogrel could save thousands of lives46,000-patient heart attack trial results
10. New trials for counseling caregivers and patients with Alzheimers begin
11. EuroVacc 02 HIV vaccine trial begins in February 2005

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/7/2020)... ... July 07, 2020 , ... Mediaplanet recently launched an awareness initiative ... pandemic thrust this field into the spotlight and, as a result, the Bureau ... 2026. In partnership with South University — which offers a Master’s in ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... featured in Biocompare’s latest content hub— Future Lab: COVID-19 R&D . , ... advancements, trends, news, and products within specific scientific niches. Since their launch four ...
(Date:7/2/2020)... ... 02, 2020 , ... Dr. Christine Blaine has earned a stellar ... offices located in Staten Island, Huntington and NYC, NY. Her former Manhattan clinic, ... suite at The Parlor NYC at 160 Madison Avenue. Blaine Plastic Surgery ...
(Date:7/1/2020)... ... July 01, 2020 , ... Dexur’s analysis of Medicare ... Hospital , Porter Adventist Hospital , and Sky Ridge Medical Center ... Knee Replacement. Dexur’s value analysis tracks a patient’s episode of care from the date ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... it has been selected by Codiak BioSciences to support its cleanroom build out ... the cleanroom infrastructure for the drug substance and product manufacturing for its clinical ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... ... 2020 , ... COMPLIANCY GROUP in its continued efforts to ... associates create, receive, transmit, store, and maintain protected health information (PHI) on behalf ... HIPAA compliant, ensuring the confidentiality, integrity, and availability of PHI. , HIPAA ...
(Date:7/10/2020)... Calif. (PRWEB) , ... July ... ... Review , the leading review of business and technology for the pharmaceutical ... the development and manufacturing of the highest quality pharmaceutical products. QC ...
(Date:7/7/2020)... ... July 07, 2020 , ... With ... Navajo Nation residents, the 33 nonprofits who received the latest ISA Foundation ... round of funding, the foundation awarded grants totaling $838,527 to the U.S.-based 501(c)(3) ...
Breaking Medicine Technology:
Cached News: